Pillar5 Pharma, Inc. has acquired the former Pfizer manufacturing site in Arnprior, Ontario from Keata Pharma, Inc. The lead investors in Pillar5 Pharma are Kevin Rampton and Claude Germain, who have assembled a group of investors to establish the new company and supply capital in an effort to ensure the future of the plant. “We see this as a terrific opportunity,” said Mr. Rampton, “The facility is well equipped and maintained, and there are very experienced production and management teams i...